UPDATE: Baird Starts Doximity Inc (DOCS) at Outperform

(Updated - November 16, 2021 4:34 PM EST)

Baird analyst Vikram Kesavabhotla initiates coverage on Doximity Inc (NYSE: DOCS) with a Outperform rating and a price target of $84.00.

The analyst comments "In our view, Doximity (DOCS) is a unique asset given the depth and engagement of physicians on its platform. We see a meaningful runway for growth in its core offerings for pharmaceutical and hospital/health system customers and believe DOCS can complement this over time by monetizing additional solutions and end-markets. While the valuation is admittedly rich, we think this premium level can sustain (and expand) through continued revenue growth, profitability, and strong execution."

For an analyst ratings summary and ratings history on Doximity Inc click here. For more ratings news on Doximity Inc click here.

Shares of Doximity Inc closed at $70.77 yesterday.

You May Also Be Interested In

• UPDATE: JPMorgan Downgrades HBT Financial (HBT) to Underweight
• UPDATE: JPMorgan Downgrades Huntington Bancshares (HBAN) to Neutral
• Fnac Darty SA (FNAC:FP) PT Lowered to EUR57 at Barclays